A phase I-II study of 9-cis retinoic acid and interferon-alpha2b in patients with advanced renal-cell carcinoma: an NCIC Clinical Trials Group study. [electronic resource]
Producer: 20010322Description: 1387-9 p. digitalISSN:- 0923-7534
- Adult
- Aged
- Alitretinoin
- Antineoplastic Agents -- administration & dosage
- Carcinoma, Renal Cell -- drug therapy
- Chemical and Drug Induced Liver Injury -- etiology
- Combined Modality Therapy
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Synergism
- Fatigue -- chemically induced
- Female
- Fever -- chemically induced
- Humans
- Immunologic Factors -- administration & dosage
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Kidney Neoplasms -- drug therapy
- Male
- Middle Aged
- Nephrectomy
- Pain -- chemically induced
- Recombinant Proteins
- Remission Induction
- Treatment Failure
- Tretinoin -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.